BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Monti JM, Jantos H. The effects of systemic administration and local microinjection into the central nervous system of the selective serotonin 5-HT2C receptor agonist RO-600175 on sleep and wakefulness in the rat. Behav Pharmacol 2015;26:418-26. [PMID: 25932720 DOI: 10.1097/FBP.0000000000000142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Millan MJ. Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action. Ther Adv Psychopharmacol 2022;12:20451253221105128. [PMID: 35795687 DOI: 10.1177/20451253221105128] [Reference Citation Analysis]
2 Wu Y, Wang L, Yang F, Xi W. Neural Circuits for Sleep-Wake Regulation. Adv Exp Med Biol 2020;1284:91-112. [PMID: 32852742 DOI: 10.1007/978-981-15-7086-5_8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Venzi M, David F, Bellet J, Cavaccini A, Bombardi C, Crunelli V, Di Giovanni G. Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures. Neuropharmacology 2016;108:292-304. [PMID: 27085605 DOI: 10.1016/j.neuropharm.2016.04.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]